MTIP
OSIR

Magee Thomson Investment Partners’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Magee Thomson Investment Partners’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-309
Closed -$5K – 119
2015
Q3 		$5K Buy
+309
New +$5.96K ﹤0.01% 70

Other funds holding OSIR

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

Magee Thomson Investment Partners's OSIR Position: Q4 2015 in Review

Magee Thomson Investment Partners sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q4 2015, closing a stake of 309 shares — an estimated $5K sold.

Magee Thomson Investment Partners first reported a position in OSIR in Q3 2015 and held it in 1 quarter. The position peaked at $5K in Q3 2015. 81 funds tracked by Wall St. Rank hold OSIR as of Q4 2015.

  • Magee Thomson Investment Partners reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Magee Thomson Investment Partners sold 309 Osiris Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $5K.
  • Magee Thomson Investment Partners first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2015 and held it in 1 quarter.
  • Magee Thomson Investment Partners's Osiris Therapeutics, Inc. Common Stock position peaked at $5K in Q3 2015.
  • 81 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2015.

Based on Magee Thomson Investment Partners's 13F filing for Q4 2015, filed 26 Jan 2016.